Study: Amyloid-β protein affects cognitive decline after small-sized cerebral infarction

by

A research team has confirmed that brain amyloid-β (Aβ) deposition, a biomarker for Alzheimer’s disease, is an essential predictor for post-stroke cognitive impairment (PSCI) development and cognitive decline after small-sized cerebral infarction.

Leave A Comment

Your email address will not be published. Required fields are marked *